Search

Your search keyword '"Dokurno, Pawel"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Dokurno, Pawel" Remove constraint Author: "Dokurno, Pawel"
43 results on '"Dokurno, Pawel"'

Search Results

2. The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues

3. Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate

4. Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B

5. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

6. A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinaseElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3md00439b

7. Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors

9. Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor

10. The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models

11. Theoretical studies on the structure, thermochemistry, vibrational spectroscopy, and other features of HfX(sub 6)(super 2-) (X = F, Cl, Br, I). Electrostatic energy in hexahalogenohafnates

12. Abstract 4482: S64315 (MIK665) is a potent and selective Mcl1 inhibitor with strong antitumor activity across a diverse range of hematologic tumor models

13. Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity

14. Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1

15. S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth

16. Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)

17. Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)

21. Abstract 2782: Bcl-2 selective antagonists show antitumor activity without dose limiting platelet toxicity

22. Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity

23. Corrigendum to “Structure-guided design of α-amino acid-derived Pin1 inhibitors” [Bioorg. Med. Chem. Lett. 20 (2010) 586]

25. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells

26. Abstract A212: A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor‐induced apoptosis in HCT116 colon carcinoma cells

27. Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design

28. Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping

30. Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: Protein structure-guided design and SAR

31. Structure-guided design of pyrazolo[1,5-a]pyrimidines as inhibitors of human cyclin-dependent kinase 2

32. Structure of the AAA ATPase p97

33. Crystal structure at 1.95 å resolution of the breast tumour-specific antibody SM3 complexed with its peptide epitope reveals novel hypervariable loop recognition

41. Crystal structure of the M-fragment of a-catenin: implications for modulation of cell adhesion.

43. Design and Synthesis of Pyrrolo[2,3- d ]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate.

Catalog

Books, media, physical & digital resources